Dalvance 500 MG vials
Ended Awarded
- Contract number
- SPE2DR26FCK6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,854
Award facts
- Contract value 100% obligated
- $8,854.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,854.30 for DALVANCE 500 mg vials on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DALVANCE (dalbavancin) is a long-acting antibiotic used to treat acute bacterial skin and skin structure infections, representing a specialized pharmaceutical product within the Defense Logistics Agency's medical supply chain operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999.99 million through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, and medical supplies to support military healthcare systems globally through this prime vendor vehicle. The company's federal contract portfolio demonstrates consistent capability in meeting competitive procurement requirements for specialized pharmaceuticals and medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCK6P?
SPE2DR26FCK6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26FCK6P worth?
The government has obligated $8,854 on SPE2DR26FCK6P.
Is contract SPE2DR26FCK6P an order under another contract?
Yes. SPE2DR26FCK6P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCK6P competed?
The extent of competition for SPE2DR26FCK6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award